Yasuhito Nannya, Magnus Tobiasson, Shinya Sato, Elsa Bernard, Shigeki Ohtake, June Takeda, Maria Creignou, Lanying Zhao, Manabu Kusakabe, Yuhei Shibata, et al. Post-azacitidine clone size predicts outcome of patients with myelodysplastic syndromes and related myeloid neoplasms. Blood advances. 2023
北川 順一, 松本 拓郎, 早瀬 直輝, 生駒 良和, 高田 英里, 佐藤 淑, 柴田 悠平, 中村 信彦, 玉井 洋太郎, 兼村 信宏, et al. 移植非適応初発多発性骨髄腫に対してレナリドミドを段階的に増量し、効果不十分例にエロツズマブを追加する治療戦略の検討(Dose-escalating lenalidomide and dexamethasone therapy with adapted therapy adding elotuzumab in transplant ineligible patients with NDMM). International Journal of Myeloma. 2022. 12. 3. 172-172
Nobuhiko Nakamura, Senji Kasahara, Junichi Kitagawa, Hiroshi Nakamura, Michio Sawada, Kenji Fukuno, Yuhei Shibata, Yuto Kaneda, Takeshi Hara, Nobuhiro Kanemura, et al. A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma. Experimental hematology & oncology. 2022. 11. 1. 9-9
Nobuhiko Nakamura, Nobuhiro Kanemura, Shin Lee, Kei Fujita, Tetsuji Morishita, Eri Takada, Yuhei Shibata, Senji Kasahara, Hideko Goto, Kenji Fukuno, et al. Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma. Leukemia & lymphoma. 2021. 1-8
Yotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, Ming-Chung Kuo, Yasuhito Nannya, Ko Sasaki, Kinuko Mitani, Noriko Hosoya, Nobuhiro Hiramoto, Takayuki Ishikawa, et al. Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia. Nature Communications. 2021. 12. 1
